OVERVIEW
The market for lung in vitro models is projected to hit USD 494.2 Million by 2025, at a CAGR of 17.5% during the forecast period. The key factors driving this market’s growth include growing emphasis on developing alternatives for animal testing models, developments in Cell Culture technology, and developing new in vitro 3D models.
TABLE OF CONTENT
1 Global In Vitro Lung Model Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global In Vitro Lung Model Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global In Vitro Lung Model Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global In Vitro Lung Model Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global In Vitro Lung Model Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global In Vitro Lung Model Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global In Vitro Lung Model Market – By Type (Market Size – & million/billion)
8.1 2D Models
8.2 3D Models
9 Global In Vitro Lung Model Market – By Application
9.1 Applications of 2D Models
9.1.1 Drug Discovery and Toxicology
9.1.2 3D Model Development
9.1.3 Basic Research
9.2 Applications of 3D Models
9.2.1 Drug Discovery and Toxicology
9.2.2 Physiological Research
9.2.3 Stem Cell Research and Regenerative Medicine
10 Global In Vitro Lung Model Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global In Vitro Lung Model Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global In Vitro Lung Model Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 ATCC
12.3 Lonza Group AG
12.4 Epithelix SaRL
12.5 MatTek Corporation
12.6 TissUse GmbH
12.7 MIMETAS
12.8 InSphero AG
12.9 CN Bio Innovations
12.10 Company 9
12.11 Company 10
12.12 Company 11 & more
13 Global In Vitro Lung Model Market – Appendix
13.1 Sources
13.2 Abbreviations